Preliminary but ‘nothing short of great.’ New data on CRISPR treatment for blood diseases suggest cure is possible
Ten patients treated with a CRISPR-based gene-editing therapy for the inherited blood disorders sickle cell…
Category: Pharma
STAT+: FTC says the number of pay-to-delay cases remains low, but vows to keep watch
Although more drug makers are settling patent infringement lawsuits, the U.S. Federal Trade Commission found…
STAT+: Pharmalittle: Cyberattacks and criminal gangs target Covid-19 vaccines; whistleblower raps FDA oversight
And so, another working week will soon draw to a close. Not a moment too…
STAT+: With growing usage and few generics, Medicare spending on inhalers is climbing
Over a recent seven-year period, Medicare Part D spending on inhalers used to control respiratory…
STAT+: Pharmalittle: FDA’s Hahn defends Covid-19 vaccine vetting; U.K. denies cutting corners to approve Pfizer shot
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Pharmalittle: U.K. approves Pfizer Covid-19 vaccine; Trump pressures FDA to approve Covid-19 shots
Rise and shine, everyone, another busy day is on the way. In fact, the middle…
How nanotechnology helps mRNA Covid-19 vaccines work
While the first two Covid-19 vaccines relying on messenger RNA technology speed toward regulatory approval…
STAT+: STAT+ Conversations: A conversation on drug pricing, policy, and access
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech…
STAT+: Pharmalittle: Serum Institute threatens to sue Covid-19 vaccine trial participant; U.S. agency prepares for Covid-19 vaccine fraud
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: FDA spikes a drug approval program that inadvertently led to price hikes and shortages
After years of mounting criticism, the federal government is planning to end a controversial program…
STAT+: Medicines Patent Pool expands deal for access to key HIV drug to several countries
In a bid to expand access to a key AIDS drug, ViiV Healthcare and the…
STAT+: Pharmalittle: Moderna seeking regulatory clearance for Covid-19 vaccine; charter flights begin for Pfizer vaccine
Good morning, everyone, and nice to see you again after an extended holiday break on…
STAT+: House committee wants Purdue CEO and Sackler family members to testify at opioid crisis hearing
A congressional committee has asked the chief executive officer of Purdue Pharma and some members…
STAT+: Pharmalittle: Purdue pleads guilty to opioid charges; Chinese firm files for Covid-19 vaccine approval
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on the last work…
STAT+: Pharmalittle: EU plots a crackdown on delay of generic drugs; Russia says its Covid-19 vaccine is 95% effective
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT+: Pharmalittle: AstraZeneca says its vaccine cuts Covid-19 risk by 70%; U.S. shots will ‘hopefully’ start within three weeks
Good morning. I’m Elizabeth Cooney, filling in for Ed Silverman today as he prepares to…
STAT+: NIH fails to disclose enough details about drug licensing, watchdog report finds
Amid increasing debate over the cost of prescription drugs, a federal watchdog agency found the…
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share…
STAT+: Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules
And so, another working week will soon draw to a close. Not a moment too…
As a new Covid-19 treatment arrives, hospitals scramble to solve logistical and ethical challenges
When the federal government started handing out a newly authorized Covid-19 treatment last week, some…
STAT+: To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose
As Purdue Pharma faced serious challenges to OxyContin sales, the company was advised to consider…
STAT+: Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs
Top of the morning to you and a fine one, it is. Blue skies and…
STAT+: House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies
Seeking to boost competition in the pharmaceutical industry, the House passed a bill that would…
STAT+: Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
Pharma trade group issues guidelines for improving diversity of clinical trial participants
The pharmaceutical industry’s largest lobbying organization released guidelines on Tuesday to enhance racial and ethnic…
STAT+: FDA vows to disclose data used to support emergency drug authorizations
In response to blistering criticism, the Food and Drug Administration committed to publicly disclosing reviews…
STAT+: Pharmalittle: Pfizer launches pilot program to deliver Covid-19 vaccine; Amazon announces new online pharmacy offering
Hello, everyone, and how are you today? We are doing just fine, thank you, now…
STAT Plus: New bill would create a subscription payment model to jumpstart antibiotic development
In a bid to combat antimicrobial resistance, two U.S. lawmakers have introduced a bipartisan bill…
Eager for a Covid vaccine, Trump now trusts drug companies he previously vilified
Amid the chaos and rancor of the first presidential debate, President Trump gave a dramatic…
STAT Plus: For the first time, drug makers and PBMs must jointly face an insulin price fixing lawsuit
A federal judge ruled that a Texas county can proceed with a lawsuit accusing several…
STAT Plus: Pharmalittle: Trump still insists a Covid-19 vaccine is ‘weeks away’; Regeneron antibody treatment shows promise
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT Plus: For two decades, the FDA approval process for opioids had numerous shortcomings, study finds
Over more than two decades, the Food and Drug Administration approved opioid painkillers based on…
STAT Plus: STAT+ Conversations: How Covid-19 will change drug development
Editor’s note: A live stream of the conversation will be embedded below at 1 p.m….
.jpg)
STAT Plus: Catalyst loses lawsuit accusing the FDA of unfairly approving a rival rare disease drug
In a blow to Catalyst Pharmaceuticals (CPRX), a federal judge dismissed its lawsuit accusing the…
STAT Plus: Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids
Good morning, everyone, and nice to be back after an extended weekend break. Nonetheless, time…
STAT Plus: An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame
A mandated safety program regulators rely on to minimize opioid abuse and misuse is not…
STAT Plus: With a new law, California becomes the first state to pursue its own line of generics
In a groundbreaking move, California adopted a law Monday to allow the state to develop…
STAT Plus: Pharmalittle: Operation Warp Speed is more Army than science; J&J’s Covid-19 vaccine moves forward
Good morning, one and all. Damian Garde here, filling in for Ed Silverman at the…
STAT Plus: Pharmalittle: In political ploy, Trump promises drug coupons to seniors; N.Y. plans its own Covid-19 vaccine reviews
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Not by the numbers: Former Aceto controller is charged with insider trading
File this under ‘What was he thinking?’ After spending nearly 17 years as controller at…
STAT Plus: Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Gilead to pay $97 million for allegedly using a charity to pay kickbacks to Medicare patients
Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it…
STAT Plus: HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals
In a stern rebuke, the Department of Health and Human Services has taken Eli Lilly…
STAT Plus: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds
Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that…
.jpg)
STAT Plus: Pharmalittle: FDA to set new standard for Covid-19 vaccine; J&J starts a one-shot vaccine trial
Hello, everyone, and welcome to the middle of the week. Already, you say? Well, the…
STAT Plus: FDA proposes a ‘modest’ change to a rule for policing off-label marketing
After years of controversy, the Food and Drug Administration has issued a proposed rule to…
STAT Plus: Novartis sells bonds tied to expanding access to medicines in poor countries
In a first-of-its-kind move by a large drug maker, Novartis (NVS) raised approximately $2.1 billion…
STAT Plus: Pharmalittle: Medicare wouldn’t cover emergency-use Covid-19 vaccines; 156 countries join WHO vaccine effort
Top of the morning to you, and a fine one it is. Baby blue skies…
STAT Plus: The world is racing toward Covid-19 drugs. In normal times, it takes years to get new antivirals out the door
Researchers may be racing to develop new Covid-19 treatments, but normally it has taken slightly…
STAT Plus: Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus
A group of U.S. senators is urging a bankruptcy judge to prevent Purdue Pharma from…